<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>91(7)</volume><submitter>Pickup K</submitter><pubmed_abstract>The distribution, metabolism, excretion and hepatic effects of the human hepatotoxin fenclozic acid were investigated following single oral doses of 10 mg/kg to normal and bile duct-cannulated male C57BL/6J mice. Whole body autoradiography showed distribution into all tissues except the brain, with radioactivity still detectable in blood, kidney and liver at 72 h post-dose. Mice dosed with [&lt;sup>14&lt;/sup>C]-fenclozic acid showed acute centrilobular hepatocellular necrosis, but no other regions of the liver were affected. The majority of the [&lt;sup>14&lt;/sup>C]-fenclozic acid-related material recovered was found in the urine/aqueous cage wash, (49%) whilst a smaller portion (13%) was eliminated via the faeces. Metabolic profiles for urine, bile and faecal extracts, obtained using liquid chromat</pubmed_abstract><journal>Archives of toxicology</journal><pagination>2643-2653</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5489613</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Acute liver effects, disposition and metabolic fate of [&lt;sup>14&lt;/sup>C]-fenclozic acid following oral administration to normal and bile-cannulated male C57BL/6J mice.</pubmed_title><pmcid>PMC5489613</pmcid><pubmed_authors>Partridge EA</pubmed_authors><pubmed_authors>Jones HB</pubmed_authors><pubmed_authors>Pickup K</pubmed_authors><pubmed_authors>Ratcliffe K</pubmed_authors><pubmed_authors>Wills J</pubmed_authors><pubmed_authors>Sarda S</pubmed_authors><pubmed_authors>Rodrigues A</pubmed_authors><pubmed_authors>Page C</pubmed_authors><pubmed_authors>Wilson ID</pubmed_authors><pubmed_authors>Martin S</pubmed_authors><pubmed_authors>Schulz-Utermoehl T</pubmed_authors><pubmed_authors>McCarthy A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Acute liver effects, disposition and metabolic fate of [&lt;sup>14&lt;/sup>C]-fenclozic acid following oral administration to normal and bile-cannulated male C57BL/6J mice.</name><description>The distribution, metabolism, excretion and hepatic effects of the human hepatotoxin fenclozic acid were investigated following single oral doses of 10 mg/kg to normal and bile duct-cannulated male C57BL/6J mice. Whole body autoradiography showed distribution into all tissues except the brain, with radioactivity still detectable in blood, kidney and liver at 72 h post-dose. Mice dosed with [&lt;sup>14&lt;/sup>C]-fenclozic acid showed acute centrilobular hepatocellular necrosis, but no other regions of the liver were affected. The majority of the [&lt;sup>14&lt;/sup>C]-fenclozic acid-related material recovered was found in the urine/aqueous cage wash, (49%) whilst a smaller portion (13%) was eliminated via the faeces. Metabolic profiles for urine, bile and faecal extracts, obtained using liquid chromat</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Jul</publication><modification>2025-04-04T12:29:32.163Z</modification><creation>2019-03-27T02:48:49Z</creation></dates><accession>S-EPMC5489613</accession><cross_references><pubmed>27896398</pubmed><doi>10.1007/s00204-016-1894-5</doi></cross_references></HashMap>